Skip to main content
DNA Labs India

Lyme Disease (Borrelia Burgdorferi) DNA Qualitative Real Time PCR Test

DNA Labs India | ISO 9001:2015 Certified

Lyme Disease (Borrelia Burgdorferi) DNA Qualitative Real Time PCR Test

Short Name: Lyme Disease PCR Test

Also known as: Borrelia burgdorferi PCR Test, Lyme Disease DNA Test, Lyme PCR Qualitative Test, Borrelia Real Time PCR

Lyme Disease (Borrelia Burgdorferi) DNA Qualitative Real Time PCR Test test available at DNA Labs India for ₹30,000. Uses Real Time PCR (Qualitative) on CSF / Synovial Fluid samples. Results in Results are typically available 2-3 weeks after sample receipt at the reference laboratory. Samples should be submitted by the 7th of the month.. Free home collection in 300+ cities across India.

PCRAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

This test is performed to detect the presence of Borrelia burgdorferi DNA in clinical specimens for the diagnosis of active Lyme disease. It is especially useful for confirming infection during the early stage when serological tests may be negative, for monitoring treatment efficacy, and for diagnosing Lyme-associated arthritis.

Test Code
1199
ICD Code
A69.20
Price
₹30,000
Sample Type
CSF / Synovial Fluid
Result Time
Results are typically available 2-3 weeks after sample receipt at the reference laboratory. Samples should be submitted by the 7th of the month.
Fasting Required
No
Method
Real Time PCR (Qualitative)
Step 1

Sample Collection

Ensure the Test Send Out Consent Form (Form 35) is duly completed and signed. Inform your physician about any current antibiotic therapy, as this may affect results. No fasting is required.

Method: Clinical collection by physician / Lumbar puncture / Joint aspiration

Step 2

Laboratory Analysis

CSF is collected via lumbar puncture and synovial fluid via joint aspiration. Both procedures are performed by a qualified physician. The sample is transferred into a sterile screw-capped container under aseptic conditions.

Step 3

Report Delivery

The sample must be shipped refrigerated or frozen to the testing laboratory. Handle the sample carefully to avoid contamination. Results are typically available within 2-3 weeks of sample receipt.

Timeline: Results are typically available 2-3 weeks after sample receipt at the reference laboratory. Samples should be submitted by the 7th of the month.

Patient Instructions

1
Before the Test:No fasting is required. Ensure the Test Send Out Consent Form (Form 35) is completed. Inform your physician about any antibiotic medications you are currently taking, as they may affect test results.
2
During the Test:CSF collection involves a lumbar puncture procedure, and synovial fluid collection involves joint aspiration. Both are performed by a qualified physician under sterile conditions. The procedures are typically done under local anesthesia.
3
After the Test:After sample collection, you may experience mild discomfort at the puncture site. Results will be available within 2-3 weeks and will be shared via the online portal, email, or WhatsApp.

About This Test

Who Should Get This Test

This test is performed to detect the presence of Borrelia burgdorferi DNA in clinical specimens for the diagnosis of active Lyme disease. It is especially useful for confirming infection during the early stage when serological tests may be negative, for monitoring treatment efficacy, and for diagnosing Lyme-associated arthritis.

How to Prepare

  • Duly filled Test Send Out Consent Form (Form 35) is mandatory
  • Collect 2 mL (minimum 1 mL) of CSF or synovial fluid
  • Transfer sample to a sterile screw-capped container
  • Ship sample refrigerated (2-8°C) or frozen (-20°C)
  • Label the container clearly with patient details and date/time of collection
  • Ensure aseptic technique during collection to avoid contamination
  • Transport sample to the laboratory as soon as possible

Doctor's Notes

Reviewed by — MBBS, MD (Microbiology) · Reg. No. 27670

"Lyme disease remains significantly under-diagnosed in India due to limited awareness and the overlap of its symptoms with other febrile illnesses. The qualitative real-time PCR test for Borrelia burgdorferi DNA is particularly valuable in the early phase of infection—within the first 2 to 4 weeks—when antibody-based serological tests may still return false-negative results. By detecting the pathogen's genetic material directly from CSF or synovial fluid, this assay provides definitive evidence of active infection. It is also an important tool for monitoring treatment response and diagnosing Lyme arthritis. I recommend this test for any patient presenting with erythema migrans, unexplained neurological symptoms, or joint effusion following potential tick exposure."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeCSF / Synovial Fluid
Sample Volume2 mL (1 mL minimum)
ContainerSterile screw-capped container
Collection MethodClinical collection by physician / Lumbar puncture / Joint aspiration

Sample Stability

Room Temperature: 6 hours
Refrigerated (2-8°C): 7 days
Frozen (-20°C): 30 days
Sample Rejection Criteria:
  • Sample received without the mandatory Test Send Out Consent Form (Form 35)
  • Sample volume less than 1 mL
  • Sample collected in a non-sterile or leaking container
  • Sample left at room temperature beyond 6 hours
  • Unlabeled or mislabeled samples
  • Heavily contaminated specimens

Understanding Your Results

The Lyme Disease PCR test provides a qualitative result indicating whether Borrelia burgdorferi DNA is detected or not detected in the submitted CSF or synovial fluid specimen. Results must be interpreted by a qualified physician in the context of clinical presentation, exposure history, and other laboratory findings.
📊

Detected

Borrelia burgdorferi DNA is present in the sample. This is consistent with active Lyme disease infection. Clinical correlation and initiation of appropriate antibiotic therapy should be considered by the treating physician.

📊

Not Detected

Borrelia burgdorferi DNA is not detected in the sample. This does not completely rule out Lyme disease, as the organism may not be present in the sampled fluid, or the bacterial load may be below the detection threshold. Clinical correlation and additional testing (e.g., serology) may be warranted.

⚠️ When to Consult a Doctor:

Consult an infectious disease specialist or your treating physician if you have been bitten by a tick, develop a bull's-eye rash, experience unexplained fever, fatigue, headache, joint pain, or neurological symptoms such as facial palsy or severe headache. Early diagnosis and treatment of Lyme disease is important to prevent complications.

Limitations

  • A negative result does not rule out Lyme disease, as bacterial DNA may be absent or below detection threshold in certain specimens
  • This test detects DNA and does not distinguish between viable and non-viable organisms
  • CSF or synovial fluid collection requires clinical procedures that must be performed by a qualified physician
  • This is a send-out test; turnaround time is 2-3 weeks from sample receipt at the reference laboratory
  • Results should always be interpreted in conjunction with clinical findings and epidemiological history

Risks & Considerations

  • Lumbar puncture may cause headache, back pain, or minor bleeding at the puncture site
  • Joint aspiration carries a small risk of infection, bleeding, or discomfort at the collection site
  • Allergic reaction to local anesthesia is rare but possible

Interfering Factors

  • Antibiotic therapy prior to sample collection may reduce bacterial load and affect detection
  • Improper sample storage or delayed transport can degrade DNA and affect results
  • Sample contamination during collection may lead to false results
  • Very low bacterial load in early or late-stage disease may fall below detection limits

Compare With Similar Tests

TestLyme Disease (Borrelia Burgdorferi) DNA Qualitative Real Time PCR TestLyme Disease Antibody Test (ELISA/EIA)Western Blot for Lyme DiseaseComplete Blood Count (CBC)
ComparisonLyme Disease (Borrelia Burgdorferi) DNA Qualitative Real Time PCR TestSerological tests detect antibodies produced by the immune system in response to B. burgdorferi infection. They may produce false negatives in early infection (first 2-4 weeks) before antibodies develop. The PCR test detects bacterial DNA directly and can confirm infection earlier.Western Blot is a confirmatory serological test that detects specific antibodies. It is typically performed after a positive or equivocal ELISA. The PCR test provides direct molecular evidence of the organism and is useful when serology is inconclusive.A CBC may show non-specific changes such as elevated white blood cell count in Lyme disease but cannot confirm the diagnosis. The PCR test provides specific identification of the causative organism's DNA.

Frequently Asked Questions

What is the Lyme Disease (Borrelia Burgdorferi) DNA Qualitative Real Time PCR Test?
This is a molecular diagnostic test that uses real-time PCR technology to detect the DNA of Borrelia burgdorferi, the bacterium responsible for Lyme disease, in cerebrospinal fluid (CSF) or synovial fluid samples. It provides a qualitative result indicating whether the bacterial DNA is detected or not detected.
How is this test different from a Lyme disease antibody test?
Antibody-based tests (ELISA, Western Blot) detect the immune system's response to the infection, which may take weeks to develop and can produce false negatives in early Lyme disease. The PCR test directly detects the bacterium's DNA, enabling earlier and more specific confirmation of active infection, particularly within the first 2-4 weeks of symptom onset.
What sample is required for this test?
This test requires 2 mL (minimum 1 mL) of cerebrospinal fluid (CSF) collected via lumbar puncture, or synovial fluid collected via joint aspiration. The sample must be placed in a sterile screw-capped container and shipped refrigerated or frozen.
How long does it take to get results?
Results are typically available within 2-3 weeks after the sample is received at the reference laboratory. Samples should be submitted by the 7th of the month.
When should I get this test done?
This test is recommended if you have been bitten by a tick and are experiencing symptoms of Lyme disease such as erythema migrans (bull's-eye rash), fever, headache, fatigue, joint pain, or neurological symptoms. It is especially valuable in the first 2-4 weeks after symptom onset when serological tests may not yet be positive.
Do I need to fast before this test?
No, fasting is not required for this test. However, a duly filled Test Send Out Consent Form (Form 35) is mandatory before sample collection.
What does a positive (Detected) result mean?
A 'Detected' result means that Borrelia burgdorferi DNA has been found in the sample, which is consistent with active Lyme disease infection. Your physician will interpret this result in the context of your clinical presentation and recommend appropriate treatment.
What does a negative (Not Detected) result mean?
A 'Not Detected' result means that Borrelia burgdorferi DNA was not found in the sample. This does not completely rule out Lyme disease, as the bacteria may not be present in the sampled fluid or may be below the detection threshold. Your physician may recommend additional testing if clinical suspicion remains.
Is home sample collection available for this test?
Free home sample collection is available for online bookings across India in major cities. However, since this test requires CSF or synovial fluid collection, the procedure must be performed by a qualified physician at a clinic, hospital, or through an arranged medical visit.
What is the cost of the Lyme Disease PCR Test at DNA Labs India?
The Lyme Disease (Borrelia Burgdorferi) DNA Qualitative Real Time PCR Test costs INR 30,000 at DNA Labs India. This price includes the test processing, necessary counseling, and support services. Financing options may be available.
Is this test covered by insurance or government health schemes?
Coverage for this test under government schemes such as PMJAY, CGHS, ECHS, and ESIC may vary. Private insurance coverage depends on your individual policy terms. It is recommended to check with your insurer or scheme authority for specific coverage details.
What consent form is required before taking this test?
A duly filled Test Send Out Consent Form (Form 35) is mandatory before sample collection can proceed. This is a send-out test, meaning the sample is referred to an external reference laboratory for processing. The consent form acknowledges your understanding and approval of this arrangement.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.